Medizinische Universitaet Innsbruck — Sponsor Intelligence | 8 EU Trials

Filter these 8 trials by condition, phase, country and more.

Open in Search →

8 Registered trials

4 Recruiting

1 Completed trials

3 Countries active

18 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 1 Phase II: 4 Phase IV: 3

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top IMPs

CARFILZOMIB 1 CARIPRAZINE 1 DARATUMUMAB 1 DEXAMETHASONE 1 FERRIC DERISOMALTOSE 1 FREMANEZUMAB 1 HUMAN ALPHA1-PROTEINASE INHIBITOR 1 LENVATINIB 1 LIDOCAINE HYDROCHLORIDE 1 OBINUTUZUMAB 1 PEMBROLIZUMAB 1 POMALIDOMIDE 1

All trials

8 total

Prospective analysis of the therapeutic efficacy of iron isomaltoside in combination with or without dopaminergic therapy in patients with r… Pending

2024-512117-40-00 Phase III 1 country FERRIC DERISOMALTOSE; SODIUM CHLORIDE
Daratumumab in Combination with Carfilzomib, Pomalidomide and Dexamethasone in patients with myeloma induced acute renal failure Pending

2024-514702-31-00 Phase II 1 country CARFILZOMIB; DARATUMUMAB; DEXAMETHASONE; POMALIDOMIDE
A randomized controlled, two-arm (1:1 ratio) Phase IIa trial to assess the efficacy and safety of obinutuzumab in treating adults with de no… Pending

2025-520641-69-00 Phase II 3 countries OBINUTUZUMAB
Effect of Alpha-1 Antitrypsin Supplementation in Alcohol-Associated Hepatitis-A prospective Pilot Study Recruiting

2024-515794-99-00 Phase II 1 country HUMAN ALPHA1-PROTEINASE INHIBITOR; PREDNISOLONE
Comparison of local anaesthesia and regional anaesthesia (PECS II block) on QoR-15 in patients undergoing subpectoral implantation of cardia… Recruiting

2023-508997-27-00 Phase IV 1 country LIDOCAINE HYDROCHLORIDE; ROPIVACAINE HYDROCHLORIDE
Phase II trial exploring combined neoadjuvant therapy with Pembrolizumab/Lenvatinib and adjuvant Pembrolizumab in patients with surgically r… Recruiting

2024-514821-45-00 Phase II 1 country LENVATINIB; PEMBROLIZUMAB
An open label signal detection study to evaluate the effects of cariprazine on cognitive functioning in patients with schizophrenia in need … Recruiting

2024-518042-24-00 Phase IV 1 country CARIPRAZINE
MR-Spectroscopy: Investigating neurochemical changes in brain metabolism in migraineurs before and after CGRP-Antibody treatment – a randomi… Ended

2024-517079-19-00 Phase IV 1 country FREMANEZUMAB

Showing 1–8 of 8 trials

← All sponsors A–Z